D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 70 Citations 15,684 190 World Ranking 570 National Ranking 279
Medicine D-index 98 Citations 26,185 311 World Ranking 4150 National Ranking 2345

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Gene

Allan Hildesheim mainly investigates Immunology, Cervical cancer, Internal medicine, Cancer and Gynecology. His research in Immunology intersects with topics in Papillomavirus Vaccines and Virology. He combines subjects such as Viral disease, Natural history study and Mass screening with his study of Cervical cancer.

His Internal medicine study frequently links to adjacent areas such as Oncology. His research in the fields of Squamous intraepithelial lesion overlaps with other disciplines such as Triage. His Gynecology research integrates issues from Cervix, Cervicography, Obstetrics, HPV infection and Risk factor.

His most cited work include:

  • MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins (364 citations)
  • Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000 (331 citations)
  • Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. (310 citations)

What are the main themes of his work throughout his whole career to date?

Immunology, Internal medicine, Cancer, Cervical cancer and Gynecology are his primary areas of study. He works mostly in the field of Immunology, limiting it down to topics relating to Virology and, in certain cases, Papillomavirus Vaccines. Allan Hildesheim works mostly in the field of Internal medicine, limiting it down to concerns involving Oncology and, occasionally, Prospective cohort study.

His work in Cancer addresses subjects such as Epidemiology, which are connected to disciplines such as Young adult. His Cervical cancer research includes themes of Viral disease, Human papillomavirus and Cervix. His Gynecology research incorporates elements of Colposcopy, Obstetrics, HPV infection, Cohort and Risk factor.

He most often published in these fields:

  • Immunology (41.76%)
  • Internal medicine (32.45%)
  • Cancer (24.20%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (32.45%)
  • Immunology (41.76%)
  • Cancer (24.20%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Immunology, Cancer, Confidence interval and Odds ratio. His studies in Internal medicine integrate themes in fields like Gastroenterology and Oncology. His Immunology study frequently draws connections between related disciplines such as Allele.

His Cancer research includes elements of Public health interventions and Dysplasia. In his study, Insulin is strongly linked to Case-control study, which falls under the umbrella field of Odds ratio. His work carried out in the field of Vaccination brings together such families of science as Randomized controlled trial, Cervical intraepithelial neoplasia, HPV infection and Cervix.

Between 2017 and 2021, his most popular works were:

  • Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies (57 citations)
  • Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States. (37 citations)
  • Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan (25 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Gene

Allan Hildesheim spends much of his time researching Internal medicine, Vaccine trial, Vaccination, Vaccine efficacy and Confidence interval. His studies deal with areas such as Sex organ and Oncology as well as Internal medicine. His work deals with themes such as Randomized controlled trial and HPV infection, which intersect with Vaccination.

His Vaccine efficacy research is multidisciplinary, incorporating elements of Genotype and Human papillomavirus. His study looks at the relationship between Serology and topics such as Real-time polymerase chain reaction, which overlap with Immunology. His Immunology research includes themes of Linkage disequilibrium and Allele.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000

Sophia S. Wang;Mark E. Sherman;Allan Hildesheim;James V. Lacey.
Cancer (2004)

504 Citations

MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins

Srikumar Sengupta;Johan A. den Boon;I-How Chen;Michael A. Newton.
Proceedings of the National Academy of Sciences of the United States of America (2008)

502 Citations

Host and viral genetics and risk of cervical cancer: a review.

Allan Hildesheim;Sophia S Wang.
Virus Research (2002)

443 Citations

Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica.

Rolando Herrero;Wim Quint;Allan Hildesheim;Paula Gonzalez.
PLOS ONE (2013)

432 Citations

An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results.

John T. Schiller;Xavier Castellsagué;Luisa L. Villa;Allan Hildesheim.
Vaccine (2008)

400 Citations

Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine

Aimée R. Kreimer;Ana Cecilia Rodriguez;Allan Hildesheim;Rolando Herrero.
Journal of the National Cancer Institute (2011)

366 Citations

A Prospective Study of Human Papillomavirus (HPV) Type 16 DNA Detection by Polymerase Chain Reaction and Its Association with Acquisition and Persistence of Other HPV Types

Kai Li Liaw;Allan Hildesheim;Robert D. Burk;Patti Gravitt.
The Journal of Infectious Diseases (2001)

345 Citations

Re: Specific Antibody Levels at the Cervix During the Menstrual Cycle of Women Vaccinated With Human Papillomavirus 16 Virus-Like Particles

Denise Nardelli-Haefliger;Daniel Wirthner;John T. Schiller;Douglas R. Lowy.
Journal of the National Cancer Institute (2004)

333 Citations

Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon.

Heidi M. Bauer;Allan Hildesheim;Mark H. Schiffman;Andrew G. Glass.
Sexually Transmitted Diseases (1993)

326 Citations

Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma.

Martha L. Hutchinson;David J. Zahniser;Mark E. Sherman;Rolando Herrero.
Cancer (1999)

325 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Allan Hildesheim

Mark Schiffman

Mark Schiffman

National Institutes of Health

Publications: 188

Eduardo L. Franco

Eduardo L. Franco

McGill University

Publications: 156

Silvia Franceschi

Silvia Franceschi

Centro di Riferimento Oncologico

Publications: 129

Robert D. Burk

Robert D. Burk

Albert Einstein College of Medicine

Publications: 117

Luisa L. Villa

Luisa L. Villa

Universidade de São Paulo

Publications: 116

Joakim Dillner

Joakim Dillner

Karolinska University Hospital

Publications: 106

Chris J.L.M. Meijer

Chris J.L.M. Meijer

Vrije Universiteit Amsterdam

Publications: 106

Tim Waterboer

Tim Waterboer

German Cancer Research Center

Publications: 95

Nicolas Wentzensen

Nicolas Wentzensen

National Institutes of Health

Publications: 94

Suzanne M. Garland

Suzanne M. Garland

Royal Women's Hospital

Publications: 93

Patti E. Gravitt

Patti E. Gravitt

George Washington University

Publications: 89

Cosette M. Wheeler

Cosette M. Wheeler

University of New Mexico

Publications: 88

François Coutlée

François Coutlée

University of Montreal

Publications: 85

Michael Pawlita

Michael Pawlita

German Cancer Research Center

Publications: 82

Anna R. Giuliano

Anna R. Giuliano

University of South Florida

Publications: 81

Rolando Herrero

Rolando Herrero

International Agency For Research On Cancer

Publications: 78

Trending Scientists

Raphael Kaplinsky

Raphael Kaplinsky

University of Sussex

Brian Elmegaard

Brian Elmegaard

Technical University of Denmark

Baosheng Jin

Baosheng Jin

Southeast University

Sunghak Lee

Sunghak Lee

Pohang University of Science and Technology

Didier Hannequin

Didier Hannequin

Inserm : Institut national de la santé et de la recherche médicale

Per Lundberg

Per Lundberg

Lund University

Sherwin Carlquist

Sherwin Carlquist

Santa Barbara Botanic Garden

Christin Carter-Su

Christin Carter-Su

University of Michigan–Ann Arbor

Mel Krajden

Mel Krajden

University of British Columbia

Jørn Hetland

Jørn Hetland

University of Bergen

Gerald J. Gorn

Gerald J. Gorn

Hong Kong Polytechnic University

Antonio Luiz Pinho Ribeiro

Antonio Luiz Pinho Ribeiro

Universidade Federal de Minas Gerais

René Schalk

René Schalk

Tilburg University

Marion Danis

Marion Danis

National Institutes of Health

Peter K. Manning

Peter K. Manning

Northeastern University

Walter Kieran Gear

Walter Kieran Gear

Cardiff University

Something went wrong. Please try again later.